Maze Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	198.77	189.25	196.81	29.16	99.92
Short-Term Investments	153.62	152.67	-	-	-
Cash & Short-Term Investments	352.38	341.92	196.81	29.16	99.92
Cash Growth	19.71%	73.73%	574.99%	-70.82%	-
Accounts Receivable	20	-	-	-	-
Other Current Assets	7.4	7.8	4.86	4.95	6.23
Total Current Assets	379.78	349.72	201.67	34.11	106.15
Net Property, Plant & Equipment	23.97	25.16	29.92	34.98	41.23
Long-Term Investments	10.56	18.11	-	-	-
Other Long-Term Assets	5.41	4.14	8.95	2.41	2.58
Total Assets	419.71	397.13	240.54	71.5	149.96
Accounts Payable	4.01	1.79	1.94	2.02	1.59
Accrued Expenses	12.39	15.97	14.1	9.81	14.87
Current Portion of Leases	4.84	4.8	4.63	4.49	4.32
Total Current Liabilities	21.24	22.56	20.67	16.32	20.78
Long-Term Debt	38.83	-	-	20.08	-
Long-Term Leases	17.55	18.51	22	25.05	27.73
Other Long-Term Liabilities	0.39	1.09	0.97	-	-
Total Long-Term Liabilities	56.77	19.61	22.97	45.13	27.73
Total Liabilities	78.01	42.16	43.64	61.45	48.51
Common Stock	0.05	0.05	0	0	0
Additional Paid-in Capital	855.54	844.35	47.24	21.84	12.81
Accumulated Other Comprehensive Income	-0.14	0.11	-	-	-
Retained Earnings	-513.76	-489.55	-358.43	-395.69	-295.27
Minority Interest	-	-	508.09	383.9	383.9
Shareholders' Equity	341.7	354.97	-311.18	-373.85	-282.46
Total Liabilities & Equity	419.71	397.13	240.54	71.5	149.96
Total Debt	61.22	23.31	26.63	49.62	32.06
Net Cash (Debt)	291.16	318.61	170.18	-20.47	67.86
Net Cash Growth	-8.62%	87.22%	-	-	-
Net Cash Per Share	5.92	7.41	62.33	-8.95	33.78
Book Value	341.7	354.97	-311.18	-373.85	-282.46
Book Value Per Share	6.94	8.26	-113.97	-163.40	-140.59
Tangible Book Value	341.7	354.97	-311.18	-373.85	-282.46
Tangible Book Value Per Share	6.94	8.26	-113.97	-163.40	-140.59

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q